drugset / Trial / NCT01581710
Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
RandomizedCrossoverQuadruple-blindPrevention
Summary
This study aims to identify markers to prove rapid improvement of lung function, airway inflammation and bronchodilator response after 2-week LTRA administration.
Timeline
- Start
- 2012-05
- Primary completion
- 2015-09
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Montelukast | Other / unclassified | 4 mg | — |
| Comparator | Montelukast | Other / unclassified | 5 mg | — |